Clincosm LogoSign in Get a demo

DIABASE; Diabetes Mellitus Registry in Second Care

Sponsor
Ziekenhuisgroep Twente (Other)
Overall Status
Recruiting
CT.gov ID
NCT05584293
Collaborator
University of Twente (Other)
1,500
Enrollment
1
Location
483.6
Anticipated Duration (Months)
3.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aims to examine real world data from medical devices and clinical outcome from diabetes mellitus patients to gain the necessary insights to be able to improve individual patient care by building a registry.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    DIABASE; Diabetes Mellitus Registry in Second Care
    Actual Study Start Date :
    Sep 11, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2050
    Anticipated Study Completion Date :
    Dec 31, 2060

    Outcome Measures

    Primary Outcome Measures

    1. Real world data from medical devices and clinical outcome in a registry [0-30 years]

      Examine real world data from medical devices and clinical outcome in a registry to gain the necessary insights to be able to improve individual patient care

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients with type 1 or type 2 diabetes

    • Patients aged 18 years or older

    • Patients visiting the outpatient clinic internal medicine in the ZGT Hospital

    • Written informed consent

    Exclusion Criteria:
    • Severe general diseases or mental disorders making the participation in the study impossible

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ziekenhuisgroep Twente Almelo Overijssel Netherlands 7609PP

    Sponsors and Collaborators

    • Ziekenhuisgroep Twente
    • University of Twente

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ziekenhuisgroep Twente
    ClinicalTrials.gov Identifier:
    NCT05584293
    Other Study ID Numbers:
    • ZGT20-40
    • W20.197
    First Posted:
    Oct 18, 2022
    Last Update Posted:
    Oct 18, 2022
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Diabetes Mellitus

    Study Results

    No Results Posted as of Oct 18, 2022